| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | 10% Owner
1 company
Besser James E is a See Remarks at Processa Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2021 | PCSA Processa Pharmaceuticals, Inc. | See Remarks | Sell | 447,771 | $10.77 | $4,821,341.61 | -14.0% | -21.9% | -66.7% | |
| Feb 22, 2021 | PCSA Processa Pharmaceuticals, Inc. | 10% Owner | Sell | 28,929 | $11.49 | $332,289.24 | -0.9% | - | - | |
| Oct 2, 2020 | PCSA Processa Pharmaceuticals, Inc. | 10% Owner | Buy | 30,000 | $4.04 | $121,200.00 | +8.0% | - | - |